Full-Time

QC Analyst

Microbiology

Posted on 12/19/2024

AbCellera Biologics

AbCellera Biologics

501-1,000 employees

Biotechnology firm specializing in antibody therapies

AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

CA$79.9k - CA$99.9kAnnually

+ Equity + Annual Bonus

Mid, Senior

Vancouver, BC, Canada

Category
Biology Lab & Research
Biology & Biotech
Requirements
  • You have a bachelor’s and 5 + years of experience or master’s degree in a relevant scientific discipline and 3+ years of QC experience
  • You have a strong knowledge and experience in Good Manufacturing Practices (GMPs), QC microbiological testing and method qualification requirements
  • You have experience with using Milliflex Oasis, Charles River Endosafe nexgen-MCS, LIMS, as well as basic benchtop techniques such as Gram staining, plate reading, vacuum filtration and LAL gel-clot
  • You have excellent interpersonal skills, ability to work independently and in a team environment, detail oriented, organized and methodical in execution of tasks
  • You have an ability to problem solve with sound analytical thinking
Responsibilities
  • Providing microbial support for aseptic product manufacturing in a cGMP regulated environment
  • Performing site support activities such as environmental monitoring, compressed gas and water system sampling within the graded manufacturing area
  • Carrying out a variety of routine microbiological techniques on utilities including but not limited to bioburden, endotoxin, TOC, conductivity and growth promotion testing on incoming microbial media. You will also be responsible for micro release testing on raw materials, in-process drug substance and final product samples
  • Evaluating and reviewing test results for conformance to appropriate specifications and highlighting any suspect results to the QC Lab Manager
  • Participating in identification, investigation (deviations/out of specifications) and resolution of problems in the microbiology lab
  • Authoring method verification protocols, SOPs, WIs and TMs based on industry standard compendial methods

AbCellera focuses on discovering and developing therapeutic antibodies for various diseases. The company uses a proprietary technology platform that combines different scientific methods to identify and create antibodies efficiently. Clients, including pharmaceutical companies and research institutions, partner with AbCellera to enhance their drug development processes. Unlike many competitors, AbCellera excels at addressing challenging targets that traditional methods struggle with. The company's goal is to advance new treatments to market while generating revenue through partnerships, discovery services, and its own therapeutic programs.

Company Stage

IPO

Total Funding

$620.9M

Headquarters

Vancouver, Canada

Founded

2012

Growth & Insights
Headcount

6 month growth

3%

1 year growth

5%

2 year growth

31%
Simplify Jobs

Simplify's Take

What believers are saying

  • Collaboration with Biogen could lead to breakthroughs in crossing the blood-brain barrier.
  • Partnership with Eli Lilly expands AbCellera's reach into diverse therapeutic areas.
  • Collaboration with Viking Global and ArrowMark accelerates new antibody drug program development.

What critics are saying

  • Peter Thiel's resignation may affect strategic leadership and investor confidence.
  • High financial stakes in partnerships could impact financial stability if programs fail.
  • Dependency on Eli Lilly partnership poses risks if disruptions or disagreements occur.

What makes AbCellera Biologics unique

  • AbCellera excels in rapid antibody discovery and development, surpassing conventional methods.
  • The company integrates proprietary technology with data science for efficient drug development.
  • AbCellera's strategic partnerships enhance its ability to tackle challenging therapeutic targets.

Help us improve and share your feedback! Did you find this helpful?